Sort
15,842 grants matching “pancreatic cancer”
DNA ADDUCTS OF AROMATIC AMINES--ANALYSIS BY MS AND P-32
$209,505Northeastern University · R01 · FY2000 · CA
Impact of circadian disruption on pancreatic cancer development and progression
$209,375Brian C Lewis · Univ Of Massachusetts Med Sch Worcester · R21 · FY2022 · ES
Host genes controlling rodent protoparvovirus tissue and species tropism
$209,375Peter Tattersall · Yale University · R21 · FY2022 · AI
Project 2: Endoscopic Photodynamic and Combination Therapy for Local and Metastatic Pancreatic Tumors
$209,212Stephen Pereira · Massachusetts General Hospital · P01 · FY2017 · CA
High-throughput, purification-free, and ultrasensitive transmembrane nanosensor arrays for digital counting of microRNA biomarkers of intact exosomes
$209,184Hao Yan · Arizona State University-Tempe Campus · R61 · FY2024 · CA
Real-time PCR expression profiling of microRNA
$209,172Thomas D Schmittgen · Ohio State University · R33 · FY2008 · CA
Real-time PCR expression profiling of microRNA
$209,151Thomas D Schmittgen · Ohio State University · R33 · FY2009 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$209,148Dartmouth College · R01 · FY2003 · CA
Real-time PCR expression profiling of microRNA
$209,130Thomas D Schmittgen · Ohio State University · R33 · FY2010 · CA
Mitochondrial control of epigenetic reprogramming in pancreatic tumorigenesis
$208,973Rohit Chandwani · Weill Medical Coll Of Cornell Univ · R21 · FY2021 · CA
Mechanisms of anti-tumor activity of group A Streptococcus in pancreatic adenocarcinoma
$208,916Brian A Boone · West Virginia University · R21 · FY2023 · CA
Image-Guided and Model-Based Optical Dosimetry Tools
$208,902Brian William Pogue · Massachusetts General Hospital · P01 · FY2012 · CA
An epigenetic switch controlling pancreatic cancer susceptibility
$208,871Lewis C Murtaugh · University Of Utah · R21 · FY2013 · CA
Targeting Kras in Pancreatic Cancer
$208,800Bulent Ozpolat · University Of Tx Md Anderson Can Ctr · R21 · FY2016 · CA
(PQC5)Early Detection Pancreatic Cancer by Hyperpolarized Silicon Nanoparticles
$208,800Pratip K. Bhattacharya · University Of Tx Md Anderson Can Ctr · R21 · FY2014 · CA
Co-targeting PDAC tumor cells and the microenvironment to succeed in EGFR/ErbB2-targeted therapy
$208,800Dihua Yu · University Of Tx Md Anderson Can Ctr · R21 · FY2018 · CA
(PQ4) Mutations in the histone chaperone DAXX drive pancreatic neuroendocrine tumors not ductal adenocarcinomas
$208,800Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R21 · FY2016 · CA
Inhibition of Stromal-Derived DKK3 to Enhance the Response of Pancreatic Cancer to Immunotherapy
$208,800Rosa F. Hwang · University Of Tx Md Anderson Can Ctr · R21 · FY2017 · CA
KRAS Muations in Plasma cfDNA as Predictor to Erolinib Response in Advanced Pancreatic Cancer
$208,800Donghui Li · University Of Tx Md Anderson Can Ctr · R21 · FY2016 · CA
Use of DND1 to counteract miRNA function in cancers
$208,800Angabin Matin · University Of Tx Md Anderson Can Ctr · R21 · FY2014 · CA
Long non-coding RNAs in pancreatic cancer
$208,800Lori Sussel · Columbia University Health Sciences · R21 · FY2014 · CA
Epigenetic Regulation by CHD7 in Colon Cancer
$208,800Marcos Estecio · University Of Tx Md Anderson Can Ctr · R21 · FY2017 · CA
Cellular Interactions between TGF-B Pathway Members and TERT and c-Myc in Gastroi
$208,770Bibhuti B Mishra · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
Regulation of Growth Factor Activity by A2 Macroglobulin
$208,760University Of California San Diego · R01 · FY2004 · CA
Fundamentals of Early and Variant Pancreatic Neoplasia
$208,732Anirban Maitra · Johns Hopkins University · P50 · FY2007 · CA